Basic information on Xenon Pharmaceuticals
Impact Score
Description Xenon Pharmaceuticals
Xenon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing neurology therapies, particularly treatments for epilepsy and other neurologic disorders.Xenon Pharmaceuticals Sustainability Performance
Climate
Society
Gender
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.
Compare Xenon Pharmaceuticals with ...
Xenon Pharmaceuticals
?
Impact Score
Climate
Society
Gender
Sources of sustainability performance
| Metric | Value | Unit | Year | PDF Name | PDF Page | |
|---|---|---|---|---|---|---|
Harassment and Discrimination at the Workplace | ||||||
| Yes | 2024 | Code of Conduct and Ethics-Final-March2024.pdf | 11 | |||
| Yes | 2024 | Code of Conduct and Ethics-Final-March2024.pdf | 12 | |||
| Yes | 2024 | Code of Conduct and Ethics-Final-March2024.pdf | 10 | |||
| Yes | 2024 | Code of Conduct and Ethics-Final-March2024.pdf | 11 | |||
Union Formation and Collective Bargaining Power | ||||||
| 0 | employees | 2024 | 0000950170-25-029149.pdf | 27 | ||
| 327 | employees | 2024 | 0000950170-25-029149.pdf | 27 | ||
Women on the Board | ||||||
| 9 | Officer | 2024 | 0000950170-25-029149.pdf | 111 | ||
| 2 | Officer | 2024 | 0000950170-25-029149.pdf | 111 | ||
Find more sustainable companies
© 2025 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.Logos provided by Clearbit (https://clearbit.com/). All trademarks and logos appearing on this website are the property of their respective owners and are used here for informational and educational purposes only, under fair use guidelines. We claim no affiliation with, nor endorsement by, the companies whose trademarks and logos are displayed. This website is independent of the brands analyzed and receives no direct or indirect compensation from them.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!